Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02914964 · ClinicalTrials.gov registry record · NA

Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study

A NA study, sponsored by Terry L. Wahls.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT02914964: Completed NA study, sponsored by Terry L. Wahls.

NCT02914964 is a NA study that has completed, run by Terry L. Wahls. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02914964, a NA study, has completed, sponsored by Terry L. Wahls.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effect of the Swank Diet (low saturated fat) and the Wahls Elimination Diet (modified paleo) on fatigue levels in individuals with relapsing-remitting multiple sclerosis who have documented fatigue. Participants will follow their usual diet for 12 weeks and then be randomly assigned to follow one of the two diets for 24 weeks.

Primary Outcome

Participant questionnaire asking about fatigue: Fatigue Severity Scale score - a 9-questions scale ranging from 1 (complete disagreement with the question) to 7 (complete agreement with the questions)

Interventions

  • BEHAVIORAL Swank Diet
  • BEHAVIORAL Wahls Elimination Diet

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2016-08
Est. Completion 2025-02-26
Phase NA
Terry L. Wahls

6 total trials

What the finished NCT02914964 record still lists

NCT02914964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Swank Diet is the first listed.

NCT02914964 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02914964 about?

NCT02914964 is a clinical study titled "Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study". The purpose of this study is to compare the effect of the Swank Diet (low saturated fat) and the Wahls Elimination Diet (modified paleo) on fatigue levels in individuals with relapsing-remitting multiple sclerosis who have documented fatigue. Participants will follow their usual diet for 12 weeks an...

What is the current status of trial NCT02914964?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2016-08. Estimated completion is 2025-02-26.

What interventions are being tested in trial NCT02914964?

The interventions under investigation include: Swank Diet (BEHAVIORAL), Wahls Elimination Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT02914964?

This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02914964's enrollment target sits among peer trials

95 931st of 2000 higher than 1,066 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02914964, the US trial registry maintained by the National Library of Medicine. NCT02914964 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.